JP Morgan Chase’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$45.8M Buy
1,954,888
+140,745
+8% +$3.44M ﹤0.01% 1449
2025
Q4
$41.1M Sell
1,814,143
-104,193
-5% -$2.27M ﹤0.01% 1493
2025
Q3
$38.6M Buy
1,918,336
+1,479,839
+337% +$24.8M ﹤0.01% 1579
2025
Q2
$6.26M Sell
438,497
-33,867
-7% -$396K ﹤0.01% 2941
2025
Q1
$4.96M Sell
472,364
-6,986,044
-94% -$79M ﹤0.01% 3170
2024
Q4
$90.3M Sell
7,458,408
-2,599,248
-26% -$34M 0.01% 989
2024
Q3
$148M Buy
10,057,656
+4,361,799
+77% +$60.8M 0.01% 802
2024
Q2
$82.2M Sell
5,695,857
-1,309,246
-19% -$20.9M 0.01% 1003
2024
Q1
$114M Buy
7,005,103
+624,197
+10% +$9.76M 0.01% 882
2023
Q4
$95.1M Buy
6,380,906
+1,125,888
+21% +$12.8M 0.01% 914
2023
Q3
$59.1M Buy
5,255,018
+324,308
+7% +$3.77M 0.01% 1031
2023
Q2
$49.6M Sell
4,930,710
-6,143,203
-55% -$57M 0.01% 1132
2023
Q1
$104M Buy
11,073,913
+7,516,372
+211% +$88.7M 0.01% 777
2022
Q4
$43.5M Buy
3,557,541
+1,396,140
+65% +$17.4M 0.01% 1190
2022
Q3
$26.8M Buy
2,161,401
+1,654,968
+327% +$28.9M ﹤0.01% 1388
2022
Q2
$9.94M Buy
506,433
+151,429
+43% +$3.58M ﹤0.01% 2170
2022
Q1
$9.26M Buy
355,004
+47,881
+16% +$1.28M ﹤0.01% 2446
2021
Q4
$8.72M Buy
307,123
+135,470
+79% +$4.21M ﹤0.01% 2570
2021
Q3
$5.47M Sell
171,653
-749,206
-81% -$25.1M ﹤0.01% 2958
2021
Q2
$31.9M Sell
920,859
-880,709
-49% -$29M ﹤0.01% 1467
2021
Q1
$53.1M Sell
1,801,568
-797,793
-31% -$24.5M 0.01% 1136
2020
Q4
$79.7M Sell
2,599,361
-5,037,410
-66% -$154M 0.01% 868
2020
Q3
$204M Buy
7,636,771
+1,446,051
+23% +$36.6M 0.04% 474
2020
Q2
$133M Buy
6,190,720
+3,200,560
+107% +$70.7M 0.03% 556
2020
Q1
$67M Sell
2,990,160
-2,875,204
-49% -$78.8M 0.02% 704
2019
Q4
$173M Sell
5,865,364
-737,021
-11% -$20M 0.04% 479
2019
Q3
$176M Buy
6,602,385
+244,349
+4% +$7.33M 0.04% 476
2019
Q2
$218M Buy
6,358,036
+2,110,779
+50% +$68.5M 0.05% 423
2019
Q1
$136M Buy
4,247,257
+3,351,173
+374% +$103M 0.03% 555
2018
Q4
$28.3M Sell
896,084
-203,351
-18% -$6.66M 0.01% 1229
2018
Q3
$38.4M Buy
+1,099,435
New +$38.7M 0.01% 1176

Other funds holding ELAN